Large Molecule Injectable Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: LB47839ADEFFEN
Market Monitor Global

Abstracts

Large molecules (biologics), also called biopharmaceuticals, are a type of drugs. These are based on proteins which have a therapeutic effect.

This report contains market size and forecasts of Large Molecule Injectable Drugs in Global, including the following market information:

Global Large Molecule Injectable Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Large Molecule Injectable Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Intravenous Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Large Molecule Injectable Drugs include Biogen, AstraZeneca, Roche, Sun Pharmaceutical, Medtronic, Novartis, ??Baxter, Amgen and Pfizer and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Large Molecule Injectable Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Large Molecule Injectable Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Large Molecule Injectable Drugs Market Segment Percentages, by Type, 2021 (%)

• Intravenous Injection
• Muscle Injection
• Subcutaneous Injection

Global Large Molecule Injectable Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Large Molecule Injectable Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Large Molecule Injectable Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Large Molecule Injectable Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Large Molecule Injectable Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Large Molecule Injectable Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Biogen
• AstraZeneca
• Roche
• Sun Pharmaceutical
• Medtronic
• Novartis
• ??Baxter
• Amgen
• Pfizer
• Johnson & Johnson

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Large Molecule Injectable Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Large Molecule Injectable Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LARGE MOLECULE INJECTABLE DRUGS OVERALL MARKET SIZE

2.1 Global Large Molecule Injectable Drugs Market Size: 2021 VS 2028
2.2 Global Large Molecule Injectable Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Large Molecule Injectable Drugs Players in Global Market
3.2 Top Global Large Molecule Injectable Drugs Companies Ranked by Revenue
3.3 Global Large Molecule Injectable Drugs Revenue by Companies
3.4 Top 3 and Top 5 Large Molecule Injectable Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Large Molecule Injectable Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Large Molecule Injectable Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Large Molecule Injectable Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Large Molecule Injectable Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Large Molecule Injectable Drugs Market Size Markets, 2021 & 2028
  4.1.2 Intravenous Injection
  4.1.3 Muscle Injection
  4.1.4 Subcutaneous Injection
4.2 By Type - Global Large Molecule Injectable Drugs Revenue & Forecasts
  4.2.1 By Type - Global Large Molecule Injectable Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Large Molecule Injectable Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Large Molecule Injectable Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Large Molecule Injectable Drugs Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Large Molecule Injectable Drugs Revenue & Forecasts
  5.2.1 By Application - Global Large Molecule Injectable Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Large Molecule Injectable Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Large Molecule Injectable Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Large Molecule Injectable Drugs Market Size, 2021 & 2028
6.2 By Region - Global Large Molecule Injectable Drugs Revenue & Forecasts
  6.2.1 By Region - Global Large Molecule Injectable Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Large Molecule Injectable Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Large Molecule Injectable Drugs Revenue, 2017-2028
  6.3.2 US Large Molecule Injectable Drugs Market Size, 2017-2028
  6.3.3 Canada Large Molecule Injectable Drugs Market Size, 2017-2028
  6.3.4 Mexico Large Molecule Injectable Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Large Molecule Injectable Drugs Revenue, 2017-2028
  6.4.2 Germany Large Molecule Injectable Drugs Market Size, 2017-2028
  6.4.3 France Large Molecule Injectable Drugs Market Size, 2017-2028
  6.4.4 U.K. Large Molecule Injectable Drugs Market Size, 2017-2028
  6.4.5 Italy Large Molecule Injectable Drugs Market Size, 2017-2028
  6.4.6 Russia Large Molecule Injectable Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Large Molecule Injectable Drugs Market Size, 2017-2028
  6.4.8 Benelux Large Molecule Injectable Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Large Molecule Injectable Drugs Revenue, 2017-2028
  6.5.2 China Large Molecule Injectable Drugs Market Size, 2017-2028
  6.5.3 Japan Large Molecule Injectable Drugs Market Size, 2017-2028
  6.5.4 South Korea Large Molecule Injectable Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Large Molecule Injectable Drugs Market Size, 2017-2028
  6.5.6 India Large Molecule Injectable Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Large Molecule Injectable Drugs Revenue, 2017-2028
  6.6.2 Brazil Large Molecule Injectable Drugs Market Size, 2017-2028
  6.6.3 Argentina Large Molecule Injectable Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Large Molecule Injectable Drugs Revenue, 2017-2028
  6.7.2 Turkey Large Molecule Injectable Drugs Market Size, 2017-2028
  6.7.3 Israel Large Molecule Injectable Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Large Molecule Injectable Drugs Market Size, 2017-2028
  6.7.5 UAE Large Molecule Injectable Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Biogen
  7.1.1 Biogen Corporate Summary
  7.1.2 Biogen Business Overview
  7.1.3 Biogen Large Molecule Injectable Drugs Major Product Offerings
  7.1.4 Biogen Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
  7.1.5 Biogen Key News
7.2 AstraZeneca
  7.2.1 AstraZeneca Corporate Summary
  7.2.2 AstraZeneca Business Overview
  7.2.3 AstraZeneca Large Molecule Injectable Drugs Major Product Offerings
  7.2.4 AstraZeneca Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
  7.2.5 AstraZeneca Key News
7.3 Roche
  7.3.1 Roche Corporate Summary
  7.3.2 Roche Business Overview
  7.3.3 Roche Large Molecule Injectable Drugs Major Product Offerings
  7.3.4 Roche Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
  7.3.5 Roche Key News
7.4 Sun Pharmaceutical
  7.4.1 Sun Pharmaceutical Corporate Summary
  7.4.2 Sun Pharmaceutical Business Overview
  7.4.3 Sun Pharmaceutical Large Molecule Injectable Drugs Major Product Offerings
  7.4.4 Sun Pharmaceutical Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
  7.4.5 Sun Pharmaceutical Key News
7.5 Medtronic
  7.5.1 Medtronic Corporate Summary
  7.5.2 Medtronic Business Overview
  7.5.3 Medtronic Large Molecule Injectable Drugs Major Product Offerings
  7.5.4 Medtronic Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
  7.5.5 Medtronic Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Large Molecule Injectable Drugs Major Product Offerings
  7.6.4 Novartis Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
  7.6.5 Novartis Key News
7.7 ??Baxter
  7.7.1 ??Baxter Corporate Summary
  7.7.2 ??Baxter Business Overview
  7.7.3 ??Baxter Large Molecule Injectable Drugs Major Product Offerings
  7.7.4 ??Baxter Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
  7.7.5 ??Baxter Key News
7.8 Amgen
  7.8.1 Amgen Corporate Summary
  7.8.2 Amgen Business Overview
  7.8.3 Amgen Large Molecule Injectable Drugs Major Product Offerings
  7.8.4 Amgen Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
  7.8.5 Amgen Key News
7.9 Pfizer
  7.9.1 Pfizer Corporate Summary
  7.9.2 Pfizer Business Overview
  7.9.3 Pfizer Large Molecule Injectable Drugs Major Product Offerings
  7.9.4 Pfizer Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
  7.9.5 Pfizer Key News
7.10 Johnson & Johnson
  7.10.1 Johnson & Johnson Corporate Summary
  7.10.2 Johnson & Johnson Business Overview
  7.10.3 Johnson & Johnson Large Molecule Injectable Drugs Major Product Offerings
  7.10.4 Johnson & Johnson Large Molecule Injectable Drugs Revenue in Global Market (2017-2022)
  7.10.5 Johnson & Johnson Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Large Molecule Injectable Drugs Market Opportunities & Trends in Global Market
Table 2. Large Molecule Injectable Drugs Market Drivers in Global Market
Table 3. Large Molecule Injectable Drugs Market Restraints in Global Market
Table 4. Key Players of Large Molecule Injectable Drugs in Global Market
Table 5. Top Large Molecule Injectable Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Large Molecule Injectable Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Large Molecule Injectable Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Large Molecule Injectable Drugs Product Type
Table 9. List of Global Tier 1 Large Molecule Injectable Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Large Molecule Injectable Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Large Molecule Injectable Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Large Molecule Injectable Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Large Molecule Injectable Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Large Molecule Injectable Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Large Molecule Injectable Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Large Molecule Injectable Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Large Molecule Injectable Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Large Molecule Injectable Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Large Molecule Injectable Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Large Molecule Injectable Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Large Molecule Injectable Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Large Molecule Injectable Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Large Molecule Injectable Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Large Molecule Injectable Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Biogen Corporate Summary
Table 31. Biogen Large Molecule Injectable Drugs Product Offerings
Table 32. Biogen Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Large Molecule Injectable Drugs Product Offerings
Table 35. AstraZeneca Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Roche Corporate Summary
Table 37. Roche Large Molecule Injectable Drugs Product Offerings
Table 38. Roche Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Sun Pharmaceutical Corporate Summary
Table 40. Sun Pharmaceutical Large Molecule Injectable Drugs Product Offerings
Table 41. Sun Pharmaceutical Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Medtronic Corporate Summary
Table 43. Medtronic Large Molecule Injectable Drugs Product Offerings
Table 44. Medtronic Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Large Molecule Injectable Drugs Product Offerings
Table 47. Novartis Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)
Table 48. ??Baxter Corporate Summary
Table 49. ??Baxter Large Molecule Injectable Drugs Product Offerings
Table 50. ??Baxter Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Amgen Corporate Summary
Table 52. Amgen Large Molecule Injectable Drugs Product Offerings
Table 53. Amgen Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Large Molecule Injectable Drugs Product Offerings
Table 56. Pfizer Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Johnson & Johnson Corporate Summary
Table 58. Johnson & Johnson Large Molecule Injectable Drugs Product Offerings
Table 59. Johnson & Johnson Large Molecule Injectable Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Large Molecule Injectable Drugs Segment by Type in 2021
Figure 2. Large Molecule Injectable Drugs Segment by Application in 2021
Figure 3. Global Large Molecule Injectable Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Large Molecule Injectable Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Large Molecule Injectable Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Large Molecule Injectable Drugs Revenue in 2021
Figure 8. By Type - Global Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
Figure 12. US Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
Figure 24. China Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Large Molecule Injectable Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Large Molecule Injectable Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Biogen Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AstraZeneca Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Roche Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sun Pharmaceutical Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Medtronic Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. ??Baxter Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Amgen Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Johnson & Johnson Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)